Toxicant Induced dysregulation of parvalbumin interneuron development and function
有毒物质引起的小白蛋白中间神经元发育和功能失调
基本信息
- 批准号:10305591
- 负责人:
- 金额:$ 40.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgonistAlkanesulfonatesAlzheimer&aposs DiseaseAryl Hydrocarbon ReceptorBehaviorBenzo(a)pyreneBrainCalcium-Binding ProteinsChlorpyrifosComplexDataDevelopmentDevelopmental ProcessDioxinsDiseaseEmbryoEpilepsyEquilibriumEthersEtiologyExposure toExtracellular MatrixFunctional disorderGenerationsGenesGeneticGenetic TranscriptionGenetic studyGoalsHealthHomologous GeneHyperactivityImpairmentIntellectual functioning disabilityInterneuron functionInterneuronsInvertebratesLearningMediatingMemoryMemory impairmentMental disordersModelingMolecularMonitorNational Institute of Environmental Health SciencesNeuronsOutcomeParvalbuminsPathologyPhenotypePopulationPredispositionProtein IsoformsPublic HealthRadialReceptor ActivationResearch PersonnelRoleSchizophreniaSignal TransductionSourceStructureTestingTetrachlorodibenzodioxinTissuesToxic Environmental SubstancesToxicant exposureTranscription CoactivatorTransgenic OrganismsValproic AcidWorkZebrafishage relatedautism spectrum disorderburden of illnesscalcium indicatorcell typecritical perioddevelopmental diseasedevelopmental geneticsgene functiongenetic manipulationin vivoinformation processinginsightloss of functionmonobutyl phthalatenervous system disorderneural circuitneuroimagingneurotoxicityoptogeneticspreventprogenitorrelating to nervous systemstem cellstooltoxicanttranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Neurological diseases and psychiatric disorders account for ~28% of the global burden of disease. Our ability to
prevent and treat these diseases and disorders is hindered by their complex, multifactorial etiologies. Our long-
term goal is to help prevent neurological diseases and psychiatric disorders by using functional neuroimaging
studies in zebrafish to understand the susceptibility of neural populations to toxicant exposures during critical
periods of development. Disruptions in the balance of excitatory and inhibitory signaling contribute to a number
of neurological diseases and psychiatric disorders including hyperactivity, autism, intellectual disabilities,
schizophrenia, epilepsy, and Alzheimer’s Disease. A common theme connecting these diverse diseases and
disorders is the disrupted development of parvalbumin (PV) interneurons. Our immediate goal is to gain insight
into the molecular mechanisms mediating PV development and function and how these critical developmental
processes are disrupted by toxicant exposure. To achieve this goal, we are developing a suite of genetic tools
for visualizing the development, connectivity, and functioning of PV interneurons in vivo as well as tools for
manipulating gene function specifically in PV interneurons. In addition, we are generating transgenic lines that
allow us to visualize the assembly and functioning of excitatory circuitry in the context of our PV interneuron-
specific manipulations. Our preliminary data indicate that dlx1, 5 and 6, known regulators of GABAergic and PV
interneuron development, and multiple isoforms of PV, are downregulated following exposure to 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (dioxin, TCDD), a prototypical aryl hydrocarbon receptor (AHR) agonist. In Aim 1,
we will utilize our genetic tool kit and functional neuroimaging to determine if exposure to different AHR agonists
disrupts PV interneuron development and function. We will use cell-type specific genetic manipulations to
activate AHR in PV interneurons and determine if AHR activation alters PV interneuron function, the assembly
of excitatory circuits in the developing brain, and is sufficient to produce larval hyperactivity as well as deficits in
adult learning and memory. Mammalian Sox9 and zebrafish sox9b are AHR targets and are also downregulated
following exposure to a number of toxicants including mono-butyl phthalate, 6:2 chlorinated polyfluorinated ether
sulfonate, valproic acid, and chlorpyrifos. Mammalian Sox9 marks radial progenitor cells (RGP), an important
source of GABAergic interneurons. In Aim 2, we will determine whether zebrafish sox9b is an important
transcriptional regulator of PV development, and if PV-interneuron specific loss of sox9b is sufficient to disrupt
PV interneuron function and larval and adult behavior. In Aim 3, we will use photoconvertible indicators of neural
activity to determine the differential effects of AHR agonist exposure on embryonic and larval brain function.
Together, these studies will provide insight into the molecular mechanisms mediating PV interneuron
development and toxicant-induced disruption of this critical cell-type. The proposed studies directly contribute to
NIEHS’s Strategic Goal 1, parts c, d, & e.
项目概要/摘要
神经系统疾病和精神疾病约占全球疾病负担的 28%。
这些疾病和病症的预防和治疗受到其复杂、多因素的病因的阻碍。
长期目标是通过使用功能性神经影像学帮助预防神经系统疾病和精神疾病
对斑马鱼进行研究,以了解神经群体在关键时期对有毒物质暴露的敏感性
兴奋性和抑制性信号平衡的破坏会导致许多问题。
神经系统疾病和精神疾病,包括多动症、自闭症、智力障碍、
精神分裂症、癫痫症和阿尔茨海默病是连接这些不同疾病和疾病的共同主题。
疾病是小清蛋白 (PV) 中间神经元的发育受到干扰。我们的直接目标是获得洞察力。
研究介导PV发育和功能的分子机制以及这些关键的发育如何
为了实现这一目标,我们正在开发一套遗传工具。
用于可视化体内 PV 中间神经元的发育、连接和功能以及工具
特别是在PV中间神经元中操纵基因功能此外,我们正在产生转基因品系。
让我们能够在PV中间神经元的背景下可视化兴奋性电路的组装和功能
我们的初步数据表明,dlx1、5 和 6 是 GABAergic 和 PV 的已知调节因子。
暴露于 2,3,7,8- 后,中间神经元发育和 PV 的多种亚型都会下调
四氯二苯并-对-二恶英(二恶英,TCDD),一种典型的芳烃受体(AHR)激动剂。
我们将利用我们的遗传工具包和功能神经影像学来确定是否暴露于不同的 AHR 激动剂
破坏 PV 中间神经元的发育和功能。我们将使用细胞类型特异性基因操作来进行治疗。
激活 PV 中间神经元中的 AHR,并确定 AHR 激活是否会改变 PV 中间神经元功能、组件
发育中大脑的兴奋性回路,足以产生幼虫过度活跃以及神经元缺陷
哺乳动物 Sox9 和斑马鱼 sox9b 是 AHR 目标,也被下调。
接触多种有毒物质(包括邻苯二甲酸单丁酯、6:2 氯化多氟醚)后
磺酸盐、丙戊酸和毒死蜱是哺乳动物 Sox9 的标记,是一种重要的径向祖细胞 (RGP)。
在目标 2 中,我们将确定斑马鱼 sox9b 是否是一个重要的来源。
PV 发育的转录调节因子,如果 PV 中间神经元特异性丢失 sox9b 足以破坏
PV 中间神经元功能以及幼虫和成虫的行为在目标 3 中,我们将使用神经光转换指标。
活性以确定 AHR 激动剂暴露对胚胎和幼虫脑功能的差异影响。
总之,这些研究将深入了解介导 PV 中间神经元的分子机制
拟议的研究直接有助于这种关键细胞类型的发育和毒物诱导的破坏。
NIEHS 的战略目标 1,c、d 和 e 部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Susan Plavicki其他文献
Jessica Susan Plavicki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Susan Plavicki', 18)}}的其他基金
Toxicant Induced dysregulation of parvalbumin interneuron development and function
有毒物质引起的小白蛋白中间神经元发育和功能失调
- 批准号:
9883262 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Toxicant Induced dysregulation of parvalbumin interneuron development and function
有毒物质引起的小白蛋白中间神经元发育和功能失调
- 批准号:
10529282 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Toxicant Induced dysregulation of parvalbumin interneuron development and function
有毒物质引起的小白蛋白中间神经元发育和功能失调
- 批准号:
10087929 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Ahr2 activation and sox9b function in forebrain and cerebral vascular development
Ahr2 激活和 sox9b 在前脑和脑血管发育中的功能
- 批准号:
9386936 - 财政年份:2017
- 资助金额:
$ 40.75万 - 项目类别:
Ahr2 activation and sox9b function in forebrain and cerebral vascular development
Ahr2 激活和 sox9b 在前脑和脑血管发育中的功能
- 批准号:
8791498 - 财政年份:2014
- 资助金额:
$ 40.75万 - 项目类别:
sox9b function in cardiomyocyte and great vessel development
sox9b 在心肌细胞和大血管发育中的功能
- 批准号:
10200081 - 财政年份:2013
- 资助金额:
$ 40.75万 - 项目类别:
sox9b function in cardiomyocyte and great vessel development
sox9b 在心肌细胞和大血管发育中的功能
- 批准号:
9979907 - 财政年份:
- 资助金额:
$ 40.75万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
- 批准号:
10666206 - 财政年份:2023
- 资助金额:
$ 40.75万 - 项目类别:
Integration of epigenetic and non-coding RNA mechanism in leukemia
表观遗传和非编码RNA机制在白血病中的整合
- 批准号:
10582327 - 财政年份:2023
- 资助金额:
$ 40.75万 - 项目类别:
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 40.75万 - 项目类别:
Effects of adolescent ethanol exposure on astrocyte-neuronal crosstalk
青少年乙醇暴露对星形胶质细胞-神经元串扰的影响
- 批准号:
10590098 - 财政年份:2023
- 资助金额:
$ 40.75万 - 项目类别: